Jalios ended the year on a high and has grown by more than 15%, as in previous years. The company’s financial stability, achieved using equity capital and funded by positive outcomes since it was created in 2001, means that it can keep investing heavily in R&D (30% of its turnover) and focusing on its product strategy. By doing so, it will strengthen its position as a key player and give a consistent and sustainable response to the needs of digitalisation, which has sped up due to the health crisis.